A molecular cancer researcher and stage IV lymphoma survivor, Muhamad leads a glioma research program focused on the mechanisms driving tumour invasion, therapy resistance and precision biomarker discovery in aggressive brain cancers, including glioblastoma (GBM), with strong translational and population-relevant impact.